Statements of Cash Flow (Unaudited) (USD $)	3 Months Ended		99 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (871,346)	$ (925,995)	$ (24,730,847)
Adjustment to reconcile net loss to net cash used in operating activities
Amortization of deferred charges			4,392,456
Amortization of prepaid expenses			75,000
Warrants issued for services	73,377	202,256	3,840,824
Stock options issued for services	145,243	292,334	5,118,621
Common stock issued for services and fees	103,443	14,500	1,427,314
Purchase right agreement amortization			132,058
Depreciation and amortization of patents	9,548	7,714	152,975
Realized gain on investments			(3,911)
Realized gain on disposal of assets			(637)
(Increase) decrease in assets
Receivables			(30,461)
Prepaid expenses and other current assets	(2,392)	(8,912)	(44,148)
Increase (decrease) in liabilities
Accounts payable	(42,659)	12,058	230,089
Accounts payable - related party	(5,302)	9,485	17,326
Accrued expenses	5,753	9,614	68,332
Net cash used in operating activities	(584,335)	(386,946)	(9,355,009)
CASH FLOWS FROM INVESTING ACTIVITIES
Cost of intangibles	(26,518)	(13,544)	(466,305)
Proceeds from sale of available for sale securities			203,911
Proceeds from receipt of note receivable			100,000
Purchase of available for sale securities			(200,000)
Purchase of equipment, furniture and leasehold improvements	(13,692)	(4,750)	(199,937)
Net cash used in investing activities	(40,210)	(18,294)	(562,331)
CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of common stock, private placement			7,495,524
Common stock rescinded, private placement			(200,000)
Issuance of common stock, exercise of options and warrants	219,400		1,796,404
Issuance of common stock, exercise of purchase right agreement			45,138
Issuance of common stock, institutional investor	2,999,998		3,199,998
Repayment of notes payable			(14,970)
Proceeds from subscription receivable			19,000
Advances to stockholders			(4,933)
Proceeds from convertible notes			529,000
Advances from officers			1,498
Net cash provided by financing activities	3,219,398		12,866,659
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	2,594,853	(405,240)	2,949,319
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	359,824	953,867	5,358
CASH AND CASH EQUIVALENTS - END OF PERIOD	2,954,677	548,627	2,954,677
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION - CASH PAID DURING THE PERIOD FOR:
Interest	109	64	23,341
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued in exchange for deferred charges			3,142,400
Warrants issued in exchange for deferred charges			1,581,056
Common stock issued as settlement for accounts payable	1,607		74,708
Increase (decrease) in fair value of investment securities
Accrued interest contributed as capital			35,624
Common stock issued in the conversion of notes payable			529,000
Acquisition of automobile through loan payable			24,643
Common stock issued upon exercise of a warrant in exchange for receivable			75,000
Insurance company pay off of note payable			9,673
Receivable for issuance of common stock	200,001		210,001
Contribution of officer accrued payroll			52,129
Common stock issued for prepaid expense			$ 75,000